Most Critical Care AI Predictive Devices Come to Market Lacking Supportive Data, Study Says

Most predictive clinical decision support devices (CDS) that rely on machine learning (ML) or AI are approved and marketed without adequate proof that they deliver on their promise of improving outcomes for patients with critical illnesses, a study has found.
Source: Drug Industry Daily

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.